porcine respiratory disease complex
GPTKB entity
Statements (57)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:affects |
pigs
|
| gptkbp:associated_with |
gptkb:swine_influenza
gptkb:porcine_reproductive_and_respiratory_syndrome mycoplasma pneumonia |
| gptkbp:caused_by |
viral infections
bacterial infections |
| gptkbp:clinical_trial |
field trials
nutritional support ongoing studies epidemiological studies environmental control monitoring herd health |
| gptkbp:controls |
quarantine
culling infected animals |
| gptkbp:distribution |
worldwide
|
| gptkbp:economic_impact |
loss of productivity
increased veterinary costs reduced growth rates |
| gptkbp:future_plans |
understanding pathogen interactions
improved diagnostics novel treatment options |
| gptkbp:healthcare |
antimicrobial resistance
food safety issues zoonotic potential |
| https://www.w3.org/2000/01/rdf-schema#label |
porcine respiratory disease complex
|
| gptkbp:impact |
swine industry
|
| gptkbp:is_protected_by |
vaccination
biosecurity measures |
| gptkbp:research_focus |
pathogen identification
treatment efficacy vaccine development |
| gptkbp:risk_factor |
stress
overcrowding poor ventilation weaning stress |
| gptkbp:social_responsibility |
seasonal variations
laboratory tests clinical signs associated with stress events common in intensive farming systems |
| gptkbp:symptoms |
fever
difficulty breathing coughing nasal discharge |
| gptkbp:transmission |
direct contact
aerosol droplets |
| gptkbp:treatment |
antibiotics
antibiotic resistance vaccine efficacy anti-inflammatory drugs multifactorial nature |
| gptkbp:wildlife |
requires veterinary intervention
affects animal welfare requires herd management strategies |
| gptkbp:bfsParent |
gptkb:Porcine_reproductive_and_respiratory_syndrome_virus
|
| gptkbp:bfsLayer |
6
|